US Patent Issued to A2 BIOTHERAPEUTICS on Jan. 27 for "Engineered immune cells with receptor cross-talk" (California Inventor)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,509, issued on Jan. 27, was assigned to A2 BIOTHERAPEUTICS INC. (Agoura Hills, Calif.).

"Engineered immune cells with receptor cross-talk" was invented by Alexander Kamb (Agoura Hills, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides engineered immune cells and methods for their creation and use. The immune cells comprise activating and blocking receptors, that exhibit cross-talk between the receptors."

The patent was filed on April 8, 2024, under Application No. 18/629,423.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HI...